AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell &…
SEATTLE, May 17, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral…